Re: & Nephew merge with MMT...........................

[Guest guest]

> http://www.smith-nephew.com/news/item.jsp?id=203

Thanks Jim, thats great news. Investing $150,000,000 in resurfacing

is a great signal that it will be the wave of the future. Money

talks and bs walks!

[Guest guest]

Rog:

I agree!. I pointed this out several months ago in a number of

posts. They will wait until Corin or get approval from the

FDA. Then they can apply for approval " as safe and effective as

the predicate device " . Thus they will avoid the expense and delay

of a clinical trial.

By the way, we seem to be getting closer to approval. Maybe by the

end of the summer. Next meeting for orthopedic devices is not

until June. No way to know without official announcement by the

FDA. The manufacturers are prohibited from any premature

announcement.

(MD in NC).

(L) C+, 3/31/03 Dr. Vail

> One point of interest especially for those US citizens that

appears

> important is covered by the the following part of the press release

>

> " The BHR procedure has been used in over 27,000 patients since

1997

> and has significant clinical experience, particularly in the UK,

> Germany and Australia. & Nephew intends to pursue Food and

> Drug Administration approval of the product in the United States. "

>

> Those who are going the Belgium route will have cover back home.

>

> Rog BHR both hips 2001 Mr Treacy

>

>

[Guest guest]

Rog:

I agree!. I pointed this out several months ago in a number of

posts. They will wait until Corin or get approval from the

FDA. Then they can apply for approval " as safe and effective as

the predicate device " . Thus they will avoid the expense and delay

of a clinical trial.

By the way, we seem to be getting closer to approval. Maybe by the

end of the summer. Next meeting for orthopedic devices is not

until June. No way to know without official announcement by the

FDA. The manufacturers are prohibited from any premature

announcement.

(MD in NC).

(L) C+, 3/31/03 Dr. Vail

> One point of interest especially for those US citizens that

appears

> important is covered by the the following part of the press release

>

> " The BHR procedure has been used in over 27,000 patients since

1997

> and has significant clinical experience, particularly in the UK,

> Germany and Australia. & Nephew intends to pursue Food and

> Drug Administration approval of the product in the United States. "

>

> Those who are going the Belgium route will have cover back home.

>

> Rog BHR both hips 2001 Mr Treacy

>

>

[Guest guest]

Rog:

I agree!. I pointed this out several months ago in a number of

posts. They will wait until Corin or get approval from the

FDA. Then they can apply for approval " as safe and effective as

the predicate device " . Thus they will avoid the expense and delay

of a clinical trial.

By the way, we seem to be getting closer to approval. Maybe by the

end of the summer. Next meeting for orthopedic devices is not

until June. No way to know without official announcement by the

FDA. The manufacturers are prohibited from any premature

announcement.

(MD in NC).

(L) C+, 3/31/03 Dr. Vail

> One point of interest especially for those US citizens that

appears

> important is covered by the the following part of the press release

>

> " The BHR procedure has been used in over 27,000 patients since

1997

> and has significant clinical experience, particularly in the UK,

> Germany and Australia. & Nephew intends to pursue Food and

> Drug Administration approval of the product in the United States. "

>

> Those who are going the Belgium route will have cover back home.

>

> Rog BHR both hips 2001 Mr Treacy

>

>